David Bradley

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 586 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Association Between Specific Adipose Tissue CD4+ T-Cell Populations and Insulin Resistance in Obese Individuals

Elisa Fabbrini, Marina Cella, Stephen A. McCartney et al. · Gastroenterology · 2013 · 272 citations · Full text

Insulin Resistance, Metabolic Syndrome, Obesity +8

Weight Loss Induced by Roux-en-Y Gastric Bypass But Not Laparoscopic Adjustable Gastric Banding Increases Circulating Bile Acids

Rohit Kohli, David Bradley, Kenneth D.R. Setchell et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 265 citations · Full text

Gastric bypass and banding equally improve insulin sensitivity and β cell function

David Bradley, Caterina Conte, Bettina Mittendorfer et al. · Journal of Clinical Investigation · 2012 · 244 citations · Full text